Copy of 2026 to 2032 expected imporprojection updated 062226.xlsx

This is a pharmaceutical import projection spreadsheet detailing planned shipments of pharmaceutical products to be imported by the Department of Veterans Affairs Cooperative Studies Program Clinical Research Pharmacy Coordinating Center (CSPCRPCC) from October 2026 through October 2032. The spreadsheet documents expected shipments of investigational medications and placebos from France to Houston and from the UK to Denver, including blinded Metformin tablets (1,800,000 units per shipment at $0.01833 per unit), Metformin placebo tablets (1,800,000 units per shipment at $0.02405 per unit), Nabiximols bottles (192 units at $32.40 per unit), Nabiximols placebo bottles (809 units at $5.00 per unit), and Epidiolex placebo bottles (1,122 units at $85.10 per unit). All products are classified under HTS Code 3004.90.00 or similar pharmaceutical classifications, with temperature requirements ranging from 2-8°C to 15-30°C, and pallets noted as non-stackable.

The procurement is structured with four quarterly shipments per year (February, June, October, and one additional shipment) across the seven-year period, with all shipments assuming a 10% tariff. Each shipment is meticulously planned with specific box or pallet dimensions, weight specifications (ranging from 15.2 to 300 kg), and quantity requirements. This import projection directly supports the Federal Government's solicitation (36C24E26Q0046) for customs brokerage and transport services, indicating the government anticipates significant pharmaceutical logistics requirements and is seeking qualified contractors to manage the customs clearance and transportation of these controlled and investigational substances into the United States through designated ports of entry.